Abstract：Objective To explore the efficacy of prednisone plus propylthiouracil in the treatment of hyperthyroidism.Methods Eighty patients with hyperthyroidism admitted to our hospital from January 2019 to June 2021 were selected as the research objects, and randomly divided into the control group and the observation group with 40 cases in each group according to the random number table method. The control group was treated with propylthiouracil, while the observation group was treated with propylthiouracil combined with prednisone. The total effective rate, calcium and phosphorus metabolism index, serum hormone level, quality of life score, liver and kidney function index and incidence of adverse reactions were compared between the two groups.Results The total effective rates of observation group and control group were 97.50% and 85.00% respectively, and the total effective rate of observation group was higher than that of control group (P<0.05). After treatment, the levels of blood calcium and phosphorus in the observation group were (1.95±0.20) mmol/L and (1.20±0.29) mmol/L respectively, which were lower than those in the control group (P<0.05). After treatment, the parathyroid hormone, free triodothyronine and free thyroxine in the observation group were (230.37±74.92) pg/ml, (12.86±3.57) pmol/L and (17.92±5.73) pmol/L respectively, which were lower than those in the control group (P<0.05), and the thyroid stimulating hormone in the observation group was (2.04±0.55) mU/L, which was higher than that in the control group (P<0.05). After treatment, the scores of physiology, psychology, environment and social relations in the quality of life in the observation group were (85.07±6.29), (84.98±5.97), (84.05±6.48) and (85.16±6.73) respectively, which were higher than those in the control group (P<0.05).Conclusions Prednisone combined with propylthiouracil has a good therapeutic effect on hyperthyroidism, which can effectively improve patients' thyroid function, correct the disorder of calcium and phosphorus metabolism and improve their quality of life. Moreover, the combined use of prednisone causes no obvious damage to patients' liver and kidney functions, and is characterized by good medication safety and few adverse reactions.
Walasik S D, Kamiński G, Sudoł S I. Impact of radioiodine treatment on doppler flow parameters in the central retinal artery and ophthalmic artery in patients with hyperthyroidism[J]. J Ultrasound Med,2021,40(2):305-318.
[2]
Tulchinsky M, Brill A B. Spotlight on the association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism is keeping the highest risk from antithyroid drugs in the blind spot[J]. Clin Nucl Med,2019,44(10):789-791.
[3]
Azizi F, Abdi H, Cheraghi L, et al. Treatment of subclinical hyperthyroidism in the elderly: comparison of radioiodine and long-term methimazole treatment[J]. Thyroid,2021,31(4):545-551.
Tonacchera M, Chiovato L, Bartalena L, et al. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy[J]. J Endocrinol Invest,2020,43(2):257-265.
[6]
Törring O, Watt T, Sjölin G, et al. Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves' hyperthyroidism: a long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-item short form health status survey[J]. Thyroid,2019,29(3): 322-331.
Giesecke P, Frykman V, Wallin G, et al. All-cause and cardiovascular mortality risk after surgery versus versus radioiodine treatment for hyperthyroidism[J]. Br J Surg,2018,105(3):279-286.
2022, Vol. 33 
